Related references
Note: Only part of the references are listed.Functional characterization of 84 PALB2 variants of uncertain significance
Timothy Wiltshire et al.
GENETICS IN MEDICINE (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement
Douglas K. Owens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Molecular analysis of PALB2-associated breast cancers
Jue Er Amanda Lee et al.
JOURNAL OF PATHOLOGY (2018)
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
Zhe-Yu Hu et al.
EBIOMEDICINE (2018)
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene
A. Tavera-Tapia et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53
Suhair Lolas Hamameh et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA
Xin Yang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak et al.
NATURE GENETICS (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Non-BRCA familial breast cancer: review of reported pathology and molecular findings
Michael G. Keeney et al.
PATHOLOGY (2017)
Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families
Jun Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer
Kun Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes
Miriam J. Smith et al.
HUMAN MUTATION (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Rachel Rosenthal et al.
GENOME BIOLOGY (2016)
Detection of novel germline mutations for breast cancer in non-BRCA1/2 families
Fatima Aloraifi et al.
FEBS JOURNAL (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
Peter Bouwman et al.
JOURNAL OF PATHOLOGY (2011)
Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner
Oren Gilad et al.
CANCER RESEARCH (2010)
Breast cancer susceptibility: current knowledge and implications for genetic counselling
Tim Ripperger et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
Anna Potapova et al.
CANCER RESEARCH (2008)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
I Hedenfalk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profiles, of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers
AA Jazaeri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
